Parkinson's Disease Trial, By Invitation NCT06084533 Sponsor: Washington University School of Medicine Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06084533
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with Parkinson's disease who are at least 50 years old and have been diagnosed with the standard form of Parkinson's disease (not caused by another condition).
  • People without Parkinson's disease who are at least 50 years old, have no close family members (such as a parent or sibling) with Parkinson's disease, and show no signs of Parkinson's disease or dementia on examination.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a history of other neurological conditions, such as stroke, seizures, or multiple sclerosis.
  • People who have had brain surgery or a serious head injury in the past.
  • People with a significant ongoing medical or whole-body illness.
  • People with a severe mental health condition, such as bipolar disorder or schizophrenia.
  • People with a history of serious drug abuse.
  • People who have taken medications that block dopamine in the brain over a long period of time.
  • People who have been on long-term treatment with medications that affect the immune system or reduce inflammation.
  • People who weigh more than 300 pounds (approximately 136 kilograms).
  • People who are unable to have an MRI scan, or for whom an MRI scan would be unsafe or not tolerated.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 January 2024
Est. completion
1 February 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PET imaging studies of [11C]-CS1P1 in healthy control participants and participants with Parkinson Disease.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov